Study of ovarian cancer CTCs using Parsortix | Company Announcement
Investegate announcements from Study of ovarian cancer CTCs using Parsortix
Source: investegate.co.uk
Stay updated with breaking news from Ciara Martin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Study of ovarian cancer CTCs using Parsortix
Investegate announcements from New commercial agreement with large pharma
Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide ...
EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Study results Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual...